Skip navigation

Toggle mobile navigation

News

A syringe is being filled from a vial in front of an HIV graphic

New formulation can provide up to six months of full protection against HIV

10 February 2023

A person is setting up home testing equipment

Sciwind Biosciences Announces Initiation of Patient Dosing in Phase 3 Clinical Trials of Ecnoglutide (XW003), a Long-acting GLP-1 analog, for the Treatment of T

03 February 2023

A child is being prepared for an injection in their arm

Study: Long-acting PrEP could reduce HIV incidence, AIDS deaths in sub-Saharan Africa

27 January 2023

A patient has just received an injection in their arm

Twice-Yearly Sunlenca Works Well for Initial HIV Treatment

27 January 2023

A scientist is setting up a microscope

Astria Therapeutics Announces Positive Preliminary Results From The Phase 1a Clinical Trial Of STAR-0215 In Healthy Subjects

13 January 2023

Scientists view results on a laptop

Using machine learning models to guide the design of long-acting injectable drug formulations

13 January 2023

A syringe is being filled from a vial.

Astria Therapeutics Announces Positive Preliminary Results From The Phase 1a Clinical Trial Of STAR-0215 In Healthy Subjects

16 December 2022

A syringe is being filled from a vial.

Broadly Neutralizing Antibody Shows Promise for Long-Acting HIV Treatment

25 November 2022

A scientist is using a pipette at their workbench

Nanexa AB has received approval initiate a clinical trial of its drug candidate NEX-2

18 November 2022

Newer stories Older Stories